https://news.medxy.ai/zh/84895-2/Medxy AIzh2026-10-16T07:26:31-07:00“首尾一贯感”可能提升康复成效：一项为期3年的纵向研究的启示 https://news.medxy.ai/ja/consistent-sense-rehabilitation/Medxy AIja2026-10-16T07:26:17-07:00首尾一貫感覚がリハビリテーション成績を高める可能性：3年間縦断研究からの示唆 https://news.medxy.ai/vi/sense-of-coherence/Medxy AIvi2026-10-16T07:26:00-07:00Tăng cường kết quả phục hồi chức năng nhờ Sense of Coherence: Góc nhìn từ nghiên cứu theo dõi dọc 3 năm https://news.medxy.ai/enhancing-rehabilitation-outcomes-through-sense-of-coherence-insights-from-a-3-year-longitudinal-study/Medxy AIen2026-10-16T07:25:44-07:00Enhancing Rehabilitation Outcomes Through Sense of Coherence: Insights From a 3-Year Longitudinal Study https://news.medxy.ai/zh/digital-aid-periodontal-treatment/Medxy AIzh2026-10-16T07:25:12-07:00数字伴随应用用于牙周治疗的价值评估：来自多中心随机对照试验的启示 https://news.medxy.ai/ja/digital-companion-app/Medxy AIja2026-10-16T07:24:57-07:00歯周治療におけるデジタルコンパニオンアプリの影響を検証する：多施設ランダム化比較試験からの知見 https://news.medxy.ai/vi/digital-companion-therapy/Medxy AIvi2026-10-16T07:24:40-07:00Ứng dụng đồng hành kỹ thuật số trong điều trị nha chu: Kết quả từ một thử nghiệm ngẫu nhiên có đối chứng đa trung tâm https://news.medxy.ai/evaluating-the-impact-of-a-digital-companion-app-in-periodontal-therapy-insights-from-a-multi-center-randomised-controlled-trial/Medxy AIen2026-10-16T07:24:23-07:00Evaluating the Impact of a Digital Companion App in Periodontal Therapy: Insights from a Multi-Center Randomised Controlled Trial https://news.medxy.ai/zh/roam-eortc-trial/Medxy AIzh2026-10-16T07:23:50-07:00WHO 2级非典型脑膜瘤完全切除后辅助放射治疗可显著降低复发：ROAM/EORTC-1308 3期试验带来新证据 https://news.medxy.ai/ja/grade-2-meningioma-radiotherapy/Medxy AIja2026-10-16T07:23:35-07:00WHOグレード2異型髄膜腫の完全切除後補助放射線療法は再発を抑制する：ROAM/EORTC-1308第3相試験からの知見 https://news.medxy.ai/vi/adjuvant-radiotherapy-menigioma/Medxy AIvi2026-10-16T07:23:15-07:00Xạ trị bổ trợ giúp giảm tái phát sau cắt bỏ hoàn toàn u màng não không điển hình độ 2 theo WHO: Kết quả nổi bật từ thử nghiệm giai đoạn 3 ROAM/EORTC-1308 https://news.medxy.ai/adjuvant-radiotherapy-reduces-recurrence-after-complete-resection-of-who-grade-2-atypical-meningioma-insights-from-the-roam-eortc-1308-phase-3-trial/Medxy AIen2026-10-16T07:22:57-07:00Adjuvant Radiotherapy Reduces Recurrence After Complete Resection of WHO Grade 2 Atypical Meningioma: Insights from the ROAM/EORTC-1308 Phase 3 Trial https://news.medxy.ai/an-infant-with-extreme-hypernatremia-treated-with-peritoneal-dialysis/Medxy AIen2026-10-16T07:22:22-07:00An Infant With Extreme Hypernatremia Treated With Peritoneal Dialysis https://news.medxy.ai/ja/lupus-nephritis-care/Medxy AIja2026-10-16T07:21:47-07:00ループス腎炎ケアの質指標：2025年EULAR推奨を実装するために――作成、遵守状況、転帰への影響 https://news.medxy.ai/vi/lupus-nephritis-markers/Medxy AIvi2026-10-16T07:21:23-07:00Viêm thận lupus: bộ chỉ số chất lượng mới theo khuyến cáo EULAR 2025 và ý nghĩa đối với kết cục điều trị https://news.medxy.ai/zh/lupus-nephritis-care-2/Medxy AIzh2026-10-16T07:20:58-07:00狼疮性肾炎护理质量指标：2025年EULAR建议的实施、依从性及其对结局的影响 https://news.medxy.ai/lupus-nephritis-quality/Medxy AIen2026-10-16T07:20:33-07:00Quality indicators for lupus nephritis care: implementing the 2025 EULAR recommendations — development, adherence, and impact on outcomes https://news.medxy.ai/zh/lung-transplant-dysfunction/Medxy AIzh2026-10-16T07:19:33-07:00双肺移植后的基线肺移植物功能障碍：影响因素与长期肺功能结局 https://news.medxy.ai/ja/lung-transplant-issues/Medxy AIja2026-10-16T07:19:18-07:00両肺移植後のベースライン肺同種移植片機能障害：規定因子と長期肺転帰 https://news.medxy.ai/vi/lung-transplant-dysfunction-2/Medxy AIvi2026-10-16T07:19:00-07:00Suy chức năng mảnh ghép phổi nền sau ghép phổi hai bên: yếu tố quyết định và kết cục hô hấp dài hạn https://news.medxy.ai/baseline-lung-allograft-dysfunction-after-bilateral-lung-transplantation-determinants-and-long-term-pulmonary-outcomes/Medxy AIen2026-10-16T07:18:42-07:00Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation: Determinants and Long-Term Pulmonary Outcomes https://news.medxy.ai/zh/sonelokimab-hidradenitis-treatment/Medxy AIzh2026-10-16T07:18:07-07:00Sonelokimab：面向中重度化脓性汗腺炎的双靶点 IL-17A/F 纳米抗体新希望 https://news.medxy.ai/ja/sonelokimab-treatment/Medxy AIja2026-10-16T07:17:52-07:00化膿性汗腺炎に挑む新規治療：SonelokimabのIL-17A/F二重標的作用に期待 https://news.medxy.ai/vi/sonelokimab-il17af/Medxy AIvi2026-10-16T07:17:36-07:00Sonelokimab: Nanobody kép IL-17A/F đầy hứa hẹn cho hidradenitis suppurativa mức độ vừa đến nặng https://news.medxy.ai/sonelokimab-a-promising-dual-il-17a-f-nanobody-for-moderate-to-severe-hidradenitis-suppurativa/Medxy AIen2026-10-16T07:17:21-07:00Sonelokimab: A Promising Dual IL-17A/F Nanobody for Moderate-to-Severe Hidradenitis Suppurativa https://news.medxy.ai/zh/cleft-lip-repair/Medxy AIzh2026-10-16T07:16:44-07:00微型唇裂修复的长期对称性与美学优势：19年鼻唇肌张力线重建经验 https://news.medxy.ai/ja/84853-2/Medxy AIja2026-10-16T07:16:30-07:00微小口唇裂修復における長期的な対称性と審美的優位性：鼻唇筋張力線再建の19年にわたる経験 https://news.medxy.ai/vi/cleft-lip-repair-2/Medxy AIvi2026-10-16T07:16:11-07:00Sửa chữa khe hở môi thể vi dạng với kết quả đối xứng bền vững: Góc nhìn từ 19 năm tái tạo đường lực căng cơ mũi–môi https://news.medxy.ai/sustained-symmetry-and-aesthetic-excellence-in-microform-cleft-lip-repair-insights-from-19-years-of-nasolabial-muscle-tension-line-reconstruction/Medxy AIen2026-10-16T07:15:53-07:00Sustained Symmetry and Aesthetic Excellence in Microform Cleft Lip Repair: Insights from 19 Years of Nasolabial Muscle Tension Line Reconstruction https://news.medxy.ai/zh/bd-maintenance-treatment/Medxy AIzh2026-10-16T07:15:19-07:00首次精神病性躁狂后如何优化维持治疗？来自 BD-CAUSAL Collaboration 的研究启示 https://news.medxy.ai/ja/84840-2/Medxy AIja2026-10-16T07:15:03-07:00初回精神病性躁病後の維持療法を最適化するには？BD-CAUSAL Collaborationによる研究からの示唆 https://news.medxy.ai/vi/maintenance-treatment-optimization/Medxy AIvi2026-10-16T07:14:45-07:00Tối ưu hóa điều trị duy trì sau đợt hưng cảm loạn thần đầu tiên: Bằng chứng từ hợp tác BD-CAUSAL https://news.medxy.ai/optimizing-maintenance-therapy-after-first-episode-psychotic-mania-insights-from-the-bd-causal-collaboration/Medxy AIen2026-10-16T07:14:28-07:00Optimizing Maintenance Therapy After First Episode Psychotic Mania: Insights from the BD-CAUSAL Collaboration https://news.medxy.ai/zh/diabetes-atherosclerosis-prognosis/Medxy AIzh2026-10-16T07:13:55-07:00糖尿病与动脉粥样硬化性心血管疾病如何影响sTNFR1在脓毒症死亡中的预后价值 https://news.medxy.ai/ja/stnfr1-prognosis-sepsis/Medxy AIja2026-10-16T07:13:38-07:00敗血症死亡におけるsTNFR1の予後的意義は糖尿病とASCVDでどう変わるか https://news.medxy.ai/vi/84830-2/Medxy AIvi2026-10-16T07:13:18-07:00Ảnh hưởng của bệnh đái tháo đường và bệnh tim mạch do xơ vữa động mạch đến vai trò tiên lượng của sTNFR1 đối với tỷ lệ tử vong do nhiễm khuẩn huyết https://news.medxy.ai/impact-of-diabetes-and-atherosclerotic-cardiovascular-disease-on-the-prognostic-role-of-stnfr1-in-sepsis-mortality/Medxy AIen2026-10-16T07:13:01-07:00Impact of Diabetes and Atherosclerotic Cardiovascular Disease on the Prognostic Role of sTNFR1 in Sepsis Mortality https://news.medxy.ai/supporting-patients-with-autism-spectrum-disorder-and-neurodivergence-in-serious-illness-decision-making/Medxy AIen2026-10-16T07:12:27-07:00Supporting Patients with Autism Spectrum Disorder and Neurodivergence in Serious Illness Decision-Making https://news.medxy.ai/zh/multiple-myeloma-microenvironment/Medxy AIzh2026-10-16T07:11:56-07:00绘制多发性骨髓瘤肿瘤微环境图谱：基于疾病不同阶段单细胞分析的启示 https://news.medxy.ai/ja/tumor-microenvironment-map/Medxy AIja2026-10-16T07:11:38-07:00多発性骨髄腫における腫瘍微小環境の地図化：病期横断的な単一細胞解析から得られた知見 https://news.medxy.ai/vi/tumor-microenvironment-map-2/Medxy AIvi2026-10-16T07:11:20-07:00Bản đồ vi môi trường khối u trong đa u tủy: những phát hiện từ phân tích đơn bào qua các giai đoạn bệnh https://news.medxy.ai/mapping-the-tumor-microenvironment-in-multiple-myeloma-insights-from-single-cell-analysis-across-disease-stages/Medxy AIen2026-10-16T07:10:59-07:00Mapping the Tumor Microenvironment in Multiple Myeloma: Insights from Single-Cell Analysis Across Disease Stages https://news.medxy.ai/zh/foxf1-pah-mechanism/Medxy AIzh2026-10-16T07:10:23-07:00FOXF1 变异与肺动脉高压发病机制：从遗传易感到 BMPR2 调控 https://news.medxy.ai/ja/foxf1-pulmonary-hypertension/Medxy AIja2026-10-16T07:10:09-07:00肺動脈性肺高血圧症の病態におけるFOXF1変異の役割を解明 https://news.medxy.ai/vi/foxf1-variants-role/Medxy AIvi2026-10-16T07:09:54-07:00Vai trò của các biến thể FOXF1 trong sinh bệnh học tăng áp động mạch phổi https://news.medxy.ai/unveiling-the-role-of-foxf1-variants-in-pulmonary-arterial-hypertension-pathogenesis/Medxy AIen2026-10-16T07:09:39-07:00Unveiling the Role of FOXF1 Variants in Pulmonary Arterial Hypertension Pathogenesis https://news.medxy.ai/zh/84800-2/Medxy AIzh2026-10-16T07:09:09-07:00西班牙裔/拉丁裔成人糖尿病视网膜病变与心血管风险因素的患病率：来自 HCHS/SOL 和 SOL Ojos 研究的发现 https://news.medxy.ai/ja/diabetic-retinopathy-prevalence/Medxy AIja2026-10-16T07:08:49-07:00ヒスパニック／ラテン系成人における糖尿病網膜症と心血管リスク因子の有病率：HCHS/SOL と SOL Ojos 研究からの知見 https://news.medxy.ai/vi/diabetic-retinopathy-burden/Medxy AIvi2026-10-16T07:08:30-07:00Gánh nặng bệnh võng mạc đái tháo đường và các yếu tố nguy cơ tim mạch ở người trưởng thành Hispanic/Latino đa dạng: Kết quả từ HCHS/SOL và SOL Ojos https://news.medxy.ai/prevalence-of-diabetic-retinopathy-and-cardiovascular-risk-factors-among-diverse-hispanic-latino-adults-insights-from-the-hchs-sol-and-sol-ojos-studies/Medxy AIen2026-10-16T07:08:10-07:00Prevalence of Diabetic Retinopathy and Cardiovascular Risk Factors Among Diverse Hispanic/Latino Adults: Insights from the HCHS/SOL and SOL Ojos Studies https://news.medxy.ai/zh/parotid-surgery-nerve-visibility/Medxy AIzh2026-10-16T07:07:24-07:00腮腺手术中面神经更清晰可见：FIESTA-C 联合 MENSA MRI 的价值 https://news.medxy.ai/ja/fieasta-mri-benefits/Medxy AIja2026-10-16T07:07:09-07:00耳下腺手術における顔面神経描出を高めるFIESTA-C＋MENSA併用MRIの有用性 https://news.medxy.ai/vi/facial-nerve-mri-guidance/Medxy AIvi2026-10-16T07:06:52-07:00Nâng cao khả năng quan sát dây thần kinh mặt bằng phối hợp chuỗi MRI FIESTA-C và MENSA trong phẫu thuật tuyến mang tai https://news.medxy.ai/enhanced-visualization-of-facial-nerve-using-combined-fiesta-c-and-mensa-mri-sequences-in-parotid-gland-surgery/Medxy AIen2026-10-16T07:06:33-07:00Enhanced Visualization of Facial Nerve Using Combined FIESTA-C and MENSA MRI Sequences in Parotid Gland Surgery https://news.medxy.ai/zh/fda-surgical-ai/Medxy AIzh2026-10-16T07:05:58-07:00FDA 批准外科 AI 器械全景：创新进展、证据基础与监管挑战 https://news.medxy.ai/ja/fda-approved-surgical-ai/Medxy AIja2026-10-16T07:05:41-07:00FDA承認外科用AI機器を読み解く：技術革新、エビデンス、規制上の課題 https://news.medxy.ai/vi/ai-surgery-devices-map/Medxy AIvi2026-10-16T07:05:23-07:00Bản đồ các thiết bị AI trong phẫu thuật được FDA phê duyệt: Đổi mới, bằng chứng và thách thức quản lý https://news.medxy.ai/navigating-the-landscape-of-fda-approved-surgical-ai-devices-innovation-evidence-and-regulatory-challenges/Medxy AIen2026-10-16T07:05:06-07:00Navigating the Landscape of FDA-Approved Surgical AI Devices: Innovation, Evidence, and Regulatory Challenges https://news.medxy.ai/zh/tubal-sterilization-consent/Medxy AIzh2026-10-16T07:04:26-07:00提升输卵管绝育知情同意质量：患者教育网站的作用 https://news.medxy.ai/ja/tubal-ligation-consent/Medxy AIja2026-10-16T07:04:09-07:00卵管滅菌術のインフォームド・コンセントを高めるには：患者中心教育ウェブサイトの効果 https://news.medxy.ai/vi/improving-consent-quality/Medxy AIvi2026-10-16T07:03:50-07:00Nâng cao chất lượng đồng ý sau khi được thông tin trong triệt sản vòi trứng: tác động của một website giáo dục lấy người bệnh làm trung tâm https://news.medxy.ai/enhancing-informed-consents-in-tubal-sterilization-impact-of-a-patient-centered-educational-website/Medxy AIen2026-10-16T07:03:33-07:00Enhancing Informed Consents in Tubal Sterilization: Impact of a Patient-Centered Educational Website https://news.medxy.ai/zh/zfp36l1-liver-aging/Medxy AIzh2026-10-16T07:02:59-07:00依赖锌的 RNA 结合蛋白 ZFP36L1：调控肝细胞衰老与酒精相关性肝病恢复的关键因子 https://news.medxy.ai/ja/zfp36l1-liver-aging-3/Medxy AIja2026-10-16T07:02:42-07:00亜鉛依存性RNA結合タンパク質ZFP36L1：肝細胞老化とアルコール関連肝疾患回復を制御する重要因子 https://news.medxy.ai/vi/zfp36l1-liver-aging-2/Medxy AIvi2026-10-16T07:02:24-07:00ZFP36L1 – protein gắn RNA phụ thuộc kẽm: ‘chốt chặn’ quan trọng trong lão hóa tế bào gan và hồi phục bệnh gan do rượu https://news.medxy.ai/zinc-dependent-rna-binding-protein-zfp36l1-a-key-regulator-of-hepatocyte-senescence-and-alcohol-related-liver-disease-recovery/Medxy AIen2026-10-16T07:02:04-07:00Zinc-Dependent RNA Binding Protein ZFP36L1: A Key Regulator of Hepatocyte Senescence and Alcohol-Related Liver Disease Recovery https://news.medxy.ai/zh/hematoma-location-impact/Medxy AIzh2026-10-16T07:01:32-07:00血肿部位：急性脑内出血强化降压疗效的关键影响因素 https://news.medxy.ai/ja/84749-2/Medxy AIja2026-10-16T07:01:13-07:00血腫部位：急性脳内出血における強化降圧療法の効果を左右する重要な因子 https://news.medxy.ai/vi/hematoma-location/Medxy AIvi2026-10-16T07:00:55-07:00Vị trí khối máu tụ: yếu tố then chốt quyết định hiệu quả hạ huyết áp tích cực trong xuất huyết não cấp https://news.medxy.ai/hematoma-location-as-a-key-modifier-of-intensive-blood-pressure-lowering-outcomes-in-acute-intracerebral-hemorrhage/Medxy AIen2026-10-16T07:00:38-07:00Hematoma Location as a Key Modifier of Intensive Blood Pressure Lowering Outcomes in Acute Intracerebral Hemorrhage https://news.medxy.ai/zh/twiist-insulin-therapy/Medxy AIzh2026-10-16T06:59:59-07:00twiist 自动化胰岛素输注系统在接受胰岛素治疗的 2 型糖尿病中的疗效与安全性：twiist-T2D 关键性试验及相关证据综述 https://news.medxy.ai/ja/twiist-insulin-efficacy/Medxy AIja2026-10-16T06:59:39-07:00インスリン治療中2型糖尿病におけるtwiist自動インスリン送達システムの有効性と安全性：twiist-T2D主要試験と関連エビデンスの包括的レビュー https://news.medxy.ai/vi/84743-2/Medxy AIvi2026-10-16T06:59:21-07:00Hiệu quả và độ an toàn của hệ thống phân phối insulin tự động twiist ở bệnh nhân đái tháo đường tuýp 2 đang điều trị bằng insulin: Thử nghiệm then chốt twiist-T2D và tổng quan các bằng chứng liên quan https://news.medxy.ai/efficacy-and-safety-of-the-twiist-automated-insulin-delivery-system-in-insulin-treated-type-2-diabetes-a-comprehensive-review-of-the-twiist-t2d-pivotal-trial-and-related-evidence/Medxy AIen2026-10-16T06:59:03-07:00Efficacy and Safety of the twiist Automated Insulin Delivery System in Insulin-Treated Type 2 Diabetes: A Comprehensive Review of the twiist-T2D Pivotal Trial and Related Evidence https://news.medxy.ai/zh/palmitic-acid-heart-failure/Medxy AIzh2026-10-16T06:58:09-07:00棕榈酸与心脏肥大：揭示驱动心力衰竭的表观遗传记忆 https://news.medxy.ai/ja/palmitic-acid-heart-failure-3/Medxy AIja2026-10-16T06:57:53-07:00パルミチン酸と心肥大：心不全を駆動するエピジェネティック記憶の解明 https://news.medxy.ai/vi/palmitic-acid-heart-failure-2/Medxy AIvi2026-10-16T06:57:36-07:00Axit palmitic và phì đại tim: Giải mã ‘ký ức’ biểu sinh thúc đẩy suy tim https://news.medxy.ai/palmitic-acid-and-cardiac-hypertrophy-unveiling-the-epigenetic-memory-driving-heart-failure/Medxy AIen2026-10-16T06:57:18-07:00Palmitic Acid and Cardiac Hypertrophy: Unveiling the Epigenetic Memory Driving Heart Failure https://news.medxy.ai/zh/84734-2/Medxy AIzh2026-10-16T06:56:39-07:00OBVAM 对脑震荡相关集合功能不全伴随​​的调节功能障碍是否有效：CONCUSS 随机临床试验的发现 https://news.medxy.ai/ja/obvam-concuss-trial/Medxy AIja2026-10-16T06:56:20-07:00脳震盪関連輻輳不全に伴う調節機能障害へOBVAMは有効か：CONCUSS無作為化臨床試験の知見 https://news.medxy.ai/vi/concussion-therapy-effectiveness/Medxy AIvi2026-10-16T06:55:59-07:00Hiệu quả của liệu pháp dung hợp điều tiết/hội tụ tại phòng khám có vận động đối với rối loạn điều tiết trong thiếu hội tụ liên quan đến chấn động não: Góc nhìn từ thử nghiệm lâm sàng ngẫu nhiên CONCUSS https://news.medxy.ai/effectiveness-of-office-based-vergence-accommodative-therapy-with-movement-for-accommodative-dysfunction-in-concussion-related-convergence-insufficiency-insights-from-the-concuss-randomised-clinical/Medxy AIen2026-10-16T06:55:38-07:00Effectiveness of Office-Based Vergence/Accommodative Therapy with Movement for Accommodative Dysfunction in Concussion-Related Convergence Insufficiency: Insights from the CONCUSS Randomised Clinical Trial https://news.medxy.ai/zh/laser-vs-shockwave-treatment-2/Medxy AIzh2026-10-16T06:54:52-07:00高强度激光治疗与体外冲击波治疗在烧伤后肘管综合征中的比较疗效：一项随机对照试验 https://news.medxy.ai/ja/laser-vs-shockwave-treatment/Medxy AIja2026-10-16T06:54:31-07:00熱傷後肘部管症候群に対する高強度レーザー治療と衝撃波治療の有効性比較：ランダム化比較試験 https://news.medxy.ai/vi/84720-2/Medxy AIvi2026-10-16T06:54:11-07:00So sánh hiệu quả của liệu pháp laser cường độ cao và liệu pháp sóng xung kích ngoài cơ thể trong điều trị hội chứng ống khuỷu sau bỏng https://news.medxy.ai/comparative-effectiveness-of-high-intensity-laser-therapy-versus-shock-wave-therapy-in-post-burn-cubital-tunnel-syndrome-a-randomized-controlled-trial/Medxy AIen2026-10-16T06:53:53-07:00Comparative Effectiveness of High-Intensity Laser Therapy Versus Shock Wave Therapy in Post-Burn Cubital Tunnel Syndrome: A Randomized Controlled Trial https://news.medxy.ai/zh/deep-learning-jaw-lesions/Medxy AIzh2026-10-16T06:53:19-07:00深度学习助力颌骨纤维-骨性病变的精准鉴别 https://news.medxy.ai/ja/fibrous-bone-lesion-ai/Medxy AIja2026-10-16T06:53:03-07:00顎骨線維性・骨性病変の正確な鑑別へ向けた深層学習の活用 https://news.medxy.ai/vi/deep-learning-bone-lesions/Medxy AIvi2026-10-16T06:52:48-07:00Tăng cường deep learning để phân biệt chính xác các tổn thương xơ–xương của hàm https://news.medxy.ai/harnessing-deep-learning-for-accurate-differentiation-of-fibro-osseous-jaw-lesions/Medxy AIen2026-10-16T06:52:30-07:00Harnessing Deep Learning for Accurate Differentiation of Fibro-Osseous Jaw Lesions https://news.medxy.ai/zh/septic-shock-resuscitation-2/Medxy AIzh2026-10-16T06:51:56-07:00脓毒性休克早期复苏如何优化：液体与血管加压药的平衡 https://news.medxy.ai/ja/septic-shock-resuscitation/Medxy AIja2026-10-16T06:51:37-07:00敗血症性ショック初期蘇生の最適化：輸液と昇圧薬のバランスを考える https://news.medxy.ai/vi/sepsis-fluid-therapy/Medxy AIvi2026-10-16T06:51:19-07:00Sốc nhiễm khuẩn giai đoạn sớm: cân bằng giữa dịch truyền và thuốc vận mạch để tối ưu hồi sức ban đầu https://news.medxy.ai/optimizing-early-resuscitation-in-septic-shock-balancing-fluids-and-vasopressors/Medxy AIen2026-10-16T06:51:01-07:00Optimizing Early Resuscitation in Septic Shock: Balancing Fluids and Vasopressors https://news.medxy.ai/zh/tasit-validation/Medxy AIzh2026-10-15T12:30:16-07:00创伤性脑损伤后社会认知评估提效：挪威语简版TASIT的信度与效度验证 https://news.medxy.ai/ja/tbi-social-cognition/Medxy AIja2026-10-15T12:30:00-07:00TBI後の社会認知評価を効率化：ノルウェー語版TASIT短縮版の妥当性と信頼性 https://news.medxy.ai/vi/social-cognition-assessment/Medxy AIvi2026-10-15T12:29:42-07:00Tinh gọn đánh giá nhận thức xã hội sau chấn thương sọ não: độ hợp lệ và độ tin cậy của phiên bản ngắn tiếng Na Uy của TASIT https://news.medxy.ai/streamlining-social-cognition-assessment-post-traumatic-brain-injury-validity-and-reliability-of-the-norwegian-short-awareness-of-social-inference-test/Medxy AIen2026-10-15T12:29:24-07:00Streamlining Social Cognition Assessment Post-Traumatic Brain Injury: Validity and Reliability of the Norwegian Short-Awareness of Social Inference Test https://news.medxy.ai/zh/palate-wound-closure/Medxy AIzh2026-10-15T12:28:45-07:00腭部创面闭合哪种更优？PRF、PRGF、胶原替代材料与自然愈合的随机对照研究 https://news.medxy.ai/ja/84604-2/Medxy AIja2026-10-15T12:28:25-07:00口蓋部創面の閉鎖において、PRF、PRGF、コラーゲン代替材料、および自然治癒のいずれが優れているか？：ランダム化比較試験 https://news.medxy.ai/vi/prf-prgf-collagen-wound-healing/Medxy AIvi2026-10-15T12:28:04-07:00So sánh hiệu quả của PRF, PRGF, vật liệu thay thế collagen và liền thương tự phát trong đóng vết thương khẩu cái: Góc nhìn từ một thử nghiệm ngẫu nhiên có đối chứng https://news.medxy.ai/comparative-efficacy-of-prf-prgf-collagen-substitute-and-spontaneous-healing-in-palatal-wound-closure-insights-from-a-randomised-controlled-trial/Medxy AIen2026-10-15T12:27:43-07:00Comparative Efficacy of PRF, PRGF, Collagen Substitute, and Spontaneous Healing in Palatal Wound Closure: Insights from a Randomised Controlled Trial https://news.medxy.ai/zh/retatrutide-triple-agonist/Medxy AIzh2026-10-15T12:27:04-07:00Retatrutide：肥胖与 2 型糖尿病管理的新突破性三重激动剂 https://news.medxy.ai/ja/retatrutide-obesity-diabetes/Medxy AIja2026-10-15T12:26:47-07:00Retatrutide、肥満・2型糖尿病治療に挑む三重作動薬の新展開 https://news.medxy.ai/vi/retatrutide-treatment/Medxy AIvi2026-10-15T12:26:26-07:00Retatrutide: Chất chủ vận ba đích đầy triển vọng trong điều trị béo phì và đái tháo đường type 2 https://news.medxy.ai/retatrutide-a-breakthrough-triple-agonist-for-obesity-and-type-2-diabetes-management/Medxy AIen2026-10-15T12:26:08-07:00Retatrutide: A Breakthrough Triple Agonist for Obesity and Type 2 Diabetes Management https://news.medxy.ai/zh/therapeutic-riding-autism/Medxy AIzh2026-10-15T12:25:26-07:00治疗性骑马：改善孤独症青少年行为问题的潜在干预 https://news.medxy.ai/ja/therapeutic-riding-autism-2/Medxy AIja2026-10-15T12:25:08-07:00自閉スペクトラム症の若年者における治療的乗馬：行動面の課題に対する有望な介入 https://news.medxy.ai/vi/therapeutic-horseback-riding/Medxy AIvi2026-10-15T12:24:46-07:00Đạp ngựa trị liệu: Can thiệp đầy hứa hẹn cho các khó khăn hành vi ở trẻ vị thành niên mắc tự kỷ và bệnh đồng mắc tâm thần https://news.medxy.ai/therapeutic-horseback-riding-a-promising-intervention-for-behavioral-challenges-in-youth-with-autism-and-psychiatric-comorbidities/Medxy AIen2026-10-15T12:24:27-07:00Therapeutic Horseback Riding: A Promising Intervention for Behavioral Challenges in Youth with Autism and Psychiatric Comorbidities https://news.medxy.ai/zh/igg4-disease-cancer-risk/Medxy AIzh2026-10-15T12:23:41-07:00大型队列研究显示：IgG4相关疾病并未增加恶性肿瘤风险 https://news.medxy.ai/ja/igg4-disease-no-cancer-risk/Medxy AIja2026-10-15T12:23:24-07:00IgG4関連疾患、悪性腫瘍リスク上昇なし　大規模コホート研究が示した新知見 https://news.medxy.ai/vi/igg4-related-diseases/Medxy AIvi2026-10-15T12:23:04-07:00Bệnh liên quan đến IgG4 không làm tăng nguy cơ ác tính: Góc nhìn từ một nghiên cứu đoàn hệ quy mô lớn https://news.medxy.ai/igg4-related-disease-shows-no-increased-risk-of-malignancy-insights-from-a-large-cohort-study/Medxy AIen2026-10-15T12:22:46-07:00IgG4-Related Disease Shows No Increased Risk of Malignancy: Insights from a Large Cohort Study https://news.medxy.ai/zh/food-access-nahcc-metabolic-dysfunction-fatty-liver/Medxy AIzh2026-10-15T12:22:03-07:00食物可及性不足如何影响肝移植候选者的代谢功能障碍相关脂肪性肝病与衰弱：一项地理空间分析 https://news.medxy.ai/ja/84584-2/Medxy AIja2026-10-15T12:21:45-07:00食料へのアクセスの不足が、肝移植候補者における代謝機能障害関連脂肪性肝疾患およびフレイルに及ぼす影響 https://news.medxy.ai/vi/food-access-liver-failure/Medxy AIvi2026-10-15T12:21:23-07:00Khả năng tiếp cận thực phẩm kém ảnh hưởng ra sao đến bệnh gan chuyển hóa và tình trạng suy kiệt ở ứng viên ghép gan? Phân tích không gian địa lý https://news.medxy.ai/impact-of-poor-food-access-on-metabolic-dysfunction-associated-liver-disease-and-frailty-among-liver-transplant-candidates-a-geospatial-analysis/Medxy AIen2026-10-15T12:21:01-07:00Impact of Poor Food Access on Metabolic Dysfunction-associated Liver Disease and Frailty Among Liver Transplant Candidates: A Geospatial Analysis https://news.medxy.ai/acquired-hair-texture-alteration-after-regrowth-in-alopecia-areata-a-distinct-clinical-and-ultrastructural-phenotype/Medxy AIen2026-10-15T12:20:11-07:00Acquired Hair Texture Alteration After Regrowth in Alopecia Areata: A Distinct Clinical and Ultrastructural Phenotype https://news.medxy.ai/zh/reduce-hump-recurrence/Medxy AIzh2026-10-15T12:19:33-07:00优化固定技术，降低低鼻中隔条带保留性鼻整形术后的驼峰复发 https://news.medxy.ai/ja/84577-2/Medxy AIja2026-10-15T12:19:16-07:00固定技術の最適化による、鼻中隔軟​​骨ストリップ温存型鼻形成術後のハンプ再発の低減 https://news.medxy.ai/vi/nose-augmentation-optimization/Medxy AIvi2026-10-15T12:19:00-07:00Tối ưu kỹ thuật cố định để ngăn tái phát gồ mũi trong nâng mũi bảo tồn bằng low septal strip https://news.medxy.ai/optimizing-fixation-techniques-to-prevent-hump-recurrence-in-low-strip-preservation-rhinoplasty/Medxy AIen2026-10-15T12:18:43-07:00Optimizing Fixation Techniques to Prevent Hump Recurrence in Low Strip Preservation Rhinoplasty https://news.medxy.ai/zh/84573-2/Medxy AIzh2026-10-15T12:18:04-07:00美国在心理健康与物质使用障碍方面的支出：成本分析及对政策与护理优化的启示 https://news.medxy.ai/ja/84572-2/Medxy AIja2026-10-15T12:17:46-07:00米国におけるメンタルヘルスおよび物質使用障害への支出：費用分析と政策・ケアの最適化への示唆 https://news.medxy.ai/vi/mental-health-costs-us/Medxy AIvi2026-10-15T12:17:23-07:00Chi tiêu cho sức khỏe tâm thần và rối loạn sử dụng chất tại Hoa Kỳ: phân tích chi phí và hàm ý đối với chính sách, tối ưu hóa chăm sóc https://news.medxy.ai/mental-health-and-substance-use-disorder-expenditures-in-the-us-profiling-costs-and-implications-for-policy-and-care-optimization/Medxy AIen2026-10-15T12:17:01-07:00Mental Health and Substance Use Disorder Expenditures in the US: Profiling Costs and Implications for Policy and Care Optimization https://news.medxy.ai/zh/patient-dignity-scale/Medxy AIzh2026-10-15T12:16:05-07:00验证患者尊严量表：助力急性呼吸衰竭幸存者康复的新证据 https://news.medxy.ai/ja/patient-dignity-validation/Medxy AIja2026-10-15T12:15:48-07:00急性呼吸不全生存者の回復を支えるPatient Dignity Inventoryの妥当性検証 https://news.medxy.ai/vi/patient-dignity-index/Medxy AIvi2026-10-15T12:15:27-07:00Xác thực Chỉ số Phẩm giá Người bệnh để hỗ trợ phục hồi ở người sống sót sau suy hô hấp cấp https://news.medxy.ai/validating-the-patient-dignity-inventory-to-enhance-recovery-in-acute-respiratory-failure-survivors/Medxy AIen2026-10-15T12:15:08-07:00Validating the Patient Dignity Inventory to Enhance Recovery in Acute Respiratory Failure Survivors https://news.medxy.ai/zh/medical-interpreters-ai/Medxy AIzh2026-10-15T12:14:26-07:00医学口译员如何助力医疗韧性：AI 融入面临的机遇与挑战 https://news.medxy.ai/ja/84562-2/Medxy AIja2026-10-15T12:14:09-07:00医療通訳者は医療のレジリエンスにどう貢献するのか――AI導入に伴う機会と課題 https://news.medxy.ai/vi/medical-interpreter-role/Medxy AIvi2026-10-15T12:13:49-07:00Vai trò của thông dịch viên y khoa trong tăng cường khả năng chống chịu và những thách thức khi tích hợp trí tuệ nhân tạo https://news.medxy.ai/the-role-of-medical-interpreters-in-enhancing-resilience-and-the-challenges-for-artificial-intelligence-integration/Medxy AIen2026-10-15T12:13:30-07:00The Role of Medical Interpreters in Enhancing Resilience and the Challenges for Artificial Intelligence Integration https://news.medxy.ai/zh/hemophilia-diagnosis/Medxy AIzh2026-10-15T12:12:38-07:00血友病携带者与女性患者的识别与诊断：全面临床策略 https://news.medxy.ai/ja/hemophilia-diagnosis-3/Medxy AIja2026-10-15T12:12:23-07:00血友病保因者と女性患者の診断・評価をどう進めるか：包括的な臨床アプローチ https://news.medxy.ai/vi/hemophilia-diagnosis-2/Medxy AIvi2026-10-15T12:12:06-07:00Nhận diện và chẩn đoán người mang gen hemophilia cùng phụ nữ mắc bệnh: tiếp cận lâm sàng toàn diện https://news.medxy.ai/identifying-and-diagnosing-carriers-and-females-with-hemophilia-a-comprehensive-clinical-approach/Medxy AIen2026-10-15T12:11:48-07:00Identifying and Diagnosing Carriers and Females with Hemophilia: A Comprehensive Clinical Approach https://news.medxy.ai/ja/gina-2026-strategy-summary/Medxy AIja2026-10-15T12:11:11-07:00GINA 2026戦略レポート要点：エグゼクティブサマリーと主な改訂点 https://news.medxy.ai/vi/gina-strategy-2026/Medxy AIvi2026-10-15T12:10:41-07:00Báo cáo Chiến lược GINA 2026: Tóm tắt điều hành và những thay đổi then chốt https://news.medxy.ai/zh/84551-2/Medxy AIzh2026-10-15T12:10:11-07:00GINA 2026 战略报告：执行摘要与关键变更 https://news.medxy.ai/2026-global-initiative-for-asthma-gina-strategy-report-executive-summary-and-key-changes/Medxy AIen2026-10-15T12:09:44-07:002026 Global Initiative for Asthma (GINA) Strategy Report: Executive Summary and Key Changes https://news.medxy.ai/zh/diabetes-impact-dmek/Medxy AIzh2026-10-15T12:08:37-07:00供体糖尿病严重程度会影响DMEK术后1年结局吗？——来自糖尿病内皮角膜移植研究的证据 https://news.medxy.ai/ja/donor-diabetes-severity/Medxy AIja2026-10-15T12:08:18-07:00ドナー糖尿病重症度はDMEK後1年成績に影響するのか：Diabetes Endothelial Keratoplasty Studyからの知見 https://news.medxy.ai/vi/diabetes-impact-dmek-2/Medxy AIvi2026-10-15T12:07:57-07:00Mức độ nặng của đái tháo đường ở người hiến giác mạc có ảnh hưởng thế nào đến kết cục 1 năm sau DMEK? Phân tích từ Nghiên cứu Ghép nội mô giác mạc ở người hiến có đái tháo đường https://news.medxy.ai/impact-of-donor-diabetes-severity-on-1-year-outcomes-after-descemet-membrane-endothelial-keratoplasty-insights-from-the-diabetes-endothelial-keratoplasty-study/Medxy AIen2026-10-15T12:07:36-07:00Impact of Donor Diabetes Severity on 1-Year Outcomes After Descemet Membrane Endothelial Keratoplasty: Insights from the Diabetes Endothelial Keratoplasty Study https://news.medxy.ai/zh/transoral-laser-throat-surgery/Medxy AIzh2026-10-15T12:06:52-07:00提升喉癌手术精准度：经口激光声带切除术中的离体共聚焦切缘评估 https://news.medxy.ai/ja/cordectomy-accuracy/Medxy AIja2026-10-15T12:06:33-07:00声門癌手術の精度向上：経口的レーザー cordectomy における ex vivo 共焦点断端評価 https://news.medxy.ai/vi/laryngectomy-laser-accuracy/Medxy AIvi2026-10-15T12:06:12-07:00Nâng cao độ chính xác phẫu thuật: Đánh giá bờ cắt ex vivo bằng kính hiển vi đồng tiêu trong cắt thanh quản bằng laser qua đường miệng cho ung thư thanh môn https://news.medxy.ai/advancing-surgical-precision-confocal-ex-vivo-margin-assessment-in-transoral-laser-cordectomy-for-glottic-cancer/Medxy AIen2026-10-15T12:05:54-07:00Advancing Surgical Precision: Confocal Ex Vivo Margin Assessment in Transoral Laser Cordectomy for Glottic Cancer https://news.medxy.ai/zh/post-colon-cancer-crp/Medxy AIzh2026-10-15T12:05:14-07:00结肠癌术后第2天CRP：及早识别低吻合口漏风险的实用指标 https://news.medxy.ai/ja/early-crp-detection/Medxy AIja2026-10-15T12:04:57-07:00結腸癌手術後の術後2日目CRPで探る、吻合部漏出低リスクの早期判定 https://news.medxy.ai/vi/early-detection-anastomotic-leak/Medxy AIvi2026-10-15T12:04:38-07:00Phát hiện sớm nguy cơ rò miệng nối thấp bằng CRP ngày hậu phẫu thứ 2 sau phẫu thuật ung thư đại tràng https://news.medxy.ai/early-identification-of-low-anastomotic-leakage-risk-using-postoperative-day-2-c-reactive-protein-after-colon-cancer-surgery/Medxy AIen2026-10-15T12:04:21-07:00Early Identification of Low Anastomotic Leakage Risk Using Postoperative Day 2 C-Reactive Protein After Colon Cancer Surgery https://news.medxy.ai/ja/immunotherapy-rectal-cancer/Medxy AIja2026-10-15T12:03:35-07:002026年中国コンセンサスで変わる：局所進行直腸癌における免疫チェックポイント阻害薬の使い方 https://news.medxy.ai/vi/china-2026-consensus/Medxy AIvi2026-10-15T12:03:03-07:00Đồng thuận Trung Quốc 2026 đã thay đổi cách dùng thuốc ức chế điểm kiểm soát miễn dịch trong ung thư trực tràng tiến triển tại chỗ như thế nào https://news.medxy.ai/zh/2026-china-immunotherapy/Medxy AIzh2026-10-15T12:02:31-07:002026年中国共识如何重塑局部进展期直肠癌中免疫检查点抑制剂的应用 https://news.medxy.ai/how-the-2026-chinese-consensus-changes-use-of-immune-checkpoint-inhibitors-in-locally-advanced-rectal-cancer/Medxy AIen2026-10-15T12:02:04-07:00How the 2026 Chinese Consensus Changes Use of Immune Checkpoint Inhibitors in Locally Advanced Rectal Cancer https://news.medxy.ai/zh/stroke-related-vertigo/Medxy AIzh2026-10-15T12:00:52-07:00卒中相关眩晕的两种表型：急性失衡综合征与急性前庭综合征的临床与神经解剖学区分 https://news.medxy.ai/ja/stroke-dizziness-differences/Medxy AIja2026-10-15T12:00:34-07:00脳卒中関連めまいを見極める：急性平衡障害症候群と急性前庭症候群の違いを臨床と神経解剖から読み解く https://news.medxy.ai/vi/acute-vertigo-syndromes/Medxy AIvi2026-10-15T12:00:16-07:00Phân biệt Hội chứng mất thăng bằng cấp tính với Hội chứng tiền đình cấp tính trong chóng mặt do đột quỵ: Góc nhìn lâm sàng và thần kinh giải phẫu https://news.medxy.ai/differentiating-acute-imbalance-syndrome-from-acute-vestibular-syndrome-in-stroke-related-vertigo-clinical-and-neuroanatomical-insights/Medxy AIen2026-10-15T11:59:57-07:00Differentiating Acute Imbalance Syndrome from Acute Vestibular Syndrome in Stroke-Related Vertigo: Clinical and Neuroanatomical Insights https://news.medxy.ai/zh/insulin-therapy-night-nutrition/Medxy AIzh2026-10-15T11:59:18-07:00夜间肠外营养患者的胰岛素治疗：持续葡萄糖监测如何助力优化 https://news.medxy.ai/ja/cgm-insulin-optimization/Medxy AIja2026-10-15T11:59:00-07:00夜間静脈栄養患者におけるCGMを活用したインスリン治療最適化 https://news.medxy.ai/vi/insulin-optimization/Medxy AIvi2026-10-15T11:58:38-07:00Tối ưu hóa điều trị insulin bằng theo dõi glucose liên tục ở bệnh nhân nuôi dưỡng tĩnh mạch ban đêm https://news.medxy.ai/optimizing-insulin-therapy-with-continuous-glucose-monitoring-in-nocturnal-parenteral-nutrition-patients/Medxy AIen2026-10-15T11:58:20-07:00Optimizing Insulin Therapy with Continuous Glucose Monitoring in Nocturnal Parenteral Nutrition Patients https://news.medxy.ai/zh/84518-2/Medxy AIzh2026-10-15T11:57:44-07:00Disitamab Vedotin 联合替雷利珠单抗治疗经尿道无法切除的 ERBB2 阳性非肌层浸润性膀胱癌：一种新兴的治疗策略 https://news.medxy.ai/ja/84517-2/Medxy AIja2026-10-15T11:57:25-07:00経尿道的手術による切除が不可能なERBB2陽性非筋層浸潤性膀胱癌に対するジシタマブ・ベドチンとチスレリズマブの併用療法：新たな治療戦略 https://news.medxy.ai/vi/84516-2/Medxy AIvi2026-10-15T11:57:04-07:00Kết hợp Disitamab Vedotin và Tislelizumab trong điều trị ung thư bàng quang không xâm lấn lớp cơ, dương tính với ERBB2 và không thể cắt bỏ qua đường niệu đạo: Một chiến lược điều trị mới nổi https://news.medxy.ai/disitamab-vedotin-plus-tislelizumab-in-transurethrally-unresectable-erbb2-positive-non-muscle-invasive-bladder-cancer-an-emerging-therapeutic-strategy/Medxy AIen2026-10-15T11:56:43-07:00Disitamab Vedotin Plus Tislelizumab in Transurethrally Unresectable, ERBB2-Positive, Non-Muscle-Invasive Bladder Cancer: An Emerging Therapeutic Strategy https://news.medxy.ai/zh/sciatic-nerve-injury-recovery/Medxy AIzh2026-10-15T11:55:45-07:00坐骨神经受累会延长大学橄榄球股后肌群拉伤恢复：MRI与BAMIC分级提示预后 https://news.medxy.ai/ja/sciatic-nerve-hamstring-injury/Medxy AIja2026-10-15T11:55:27-07:00MRIで見える坐骨神経の関与がハムストリング損傷の復帰を遅らせる：大学アメリカンフットボール選手におけるBAMIC評価の示唆 https://news.medxy.ai/vi/sciatic-nerve-recovery/Medxy AIvi2026-10-15T11:55:07-07:00Dây thần kinh tọa làm kéo dài thời gian hồi phục ở chấn thương gân kheo của cầu thủ bóng bầu dục đại học: góc nhìn từ MRI và thang điểm BAMIC https://news.medxy.ai/sciatic-nerve-involvement-extends-recovery-in-collegiate-football-hamstring-injuries-insights-from-mri-and-bamic-grading/Medxy AIen2026-10-15T11:54:48-07:00Sciatic Nerve Involvement Extends Recovery in Collegiate Football Hamstring Injuries: Insights from MRI and BAMIC Grading https://news.medxy.ai/zh/blood-flow-restriction-training/Medxy AIzh2026-10-15T11:54:05-07:00血流限制训练助力卒中康复：下肢功能与平衡改善的新证据 https://news.medxy.ai/ja/blood-flow-restriction-training-2/Medxy AIja2026-10-15T11:53:47-07:00脳卒中リハビリテーションを高める血流制限トレーニング：下肢機能とバランスへの影響 https://news.medxy.ai/vi/stroke-recovery-training/Medxy AIvi2026-10-15T11:53:26-07:00Tăng cường phục hồi sau đột quỵ: Tác động của huấn luyện hạn chế lưu lượng máu lên chức năng chi dưới và thăng bằng https://news.medxy.ai/enhancing-stroke-rehabilitation-impact-of-blood-flow-restriction-training-on-lower-limb-function-and-balance/Medxy AIen2026-10-15T11:53:07-07:00Enhancing Stroke Rehabilitation: Impact of Blood Flow Restriction Training on Lower Limb Function and Balance https://news.medxy.ai/zh/tmj-diagnosis-efficiency/Medxy AIzh2026-10-15T11:52:25-07:00颞下颌关节紊乱诊断更高效：简短检查方案的有效性验证 https://news.medxy.ai/ja/tmj-diagnosis-efficiency-2/Medxy AIja2026-10-15T11:52:07-07:00顎関節症診断をもっと効率的に：短縮版検査プロトコルの妥当性 https://news.medxy.ai/vi/tmj-diagnosis-simplified/Medxy AIvi2026-10-15T11:51:45-07:00Rút gọn chẩn đoán rối loạn khớp thái dương hàm: Giá trị của một quy trình thăm khám ngắn https://news.medxy.ai/streamlining-temporomandibular-disorder-diagnosis-validity-of-a-brief-examination-protocol/Medxy AIen2026-10-15T11:51:27-07:00Streamlining Temporomandibular Disorder Diagnosis: Validity of a Brief Examination Protocol https://news.medxy.ai/zh/tricuspid-regurgitation-breakthrough/Medxy AIzh2026-10-15T11:50:41-07:00重度三尖瓣反流治疗迎来新突破：TRIC-I-HF试验解读 https://news.medxy.ai/ja/tricuspid-regurgitation-outcomes/Medxy AIja2026-10-15T11:50:24-07:00重症三尖弁逆流の転帰を変える：TRIC-I-HF試験が示した新知見 https://news.medxy.ai/vi/mitral-valve-repair/Medxy AIvi2026-10-15T11:50:05-07:00Sửa van ba lá nặng: Bằng chứng mới từ thử nghiệm TRIC-I-HF https://news.medxy.ai/transforming-outcomes-in-severe-tricuspid-regurgitation-insights-from-the-tric-i-hf-trial/Medxy AIen2026-10-15T11:49:45-07:00Transforming Outcomes in Severe Tricuspid Regurgitation: Insights from the TRIC-I-HF Trial